Regulating Regeneration in Europe

Regulating Regeneration in Europe

April 9, 2019

Caladrius’ Vice President of Global Regulatory Affairs, William Sietsema, discusses the global regulatory environment for regenerative medicines and the Company’s priority review designations in the U.S. and Japan. Click here to read the full article.